GENETICS OF BONE DENSITY IN MEXICAN AMERICANS - CONTINUATION
墨西哥裔美国人的骨密度遗传学 - 续
基本信息
- 批准号:7627493
- 负责人:
- 金额:$ 3.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-04-01 至 2008-03-31
- 项目状态:已结题
- 来源:
- 关键词:AgeAtherosclerosisBone DensityCandidate Disease GeneChromosome MappingChromosomesChromosomes, Human, Pair 4Computer Retrieval of Information on Scientific Projects DatabaseDiabetes MellitusEnrollmentFamilyForearmFundingGeneticGenome ScanGoalsGrantHeartHyperinsulinismIndividualInstitutionInsulinLinkLinkage DisequilibriumLod ScoreMapsMeasurementMeasuresMexican AmericansMolecularObesityOsteoporosisQuantitative Trait LociRateResearchResearch PersonnelResourcesRisk FactorsSNP genotypingSerumSourceUnited States National Institutes of HealthVisitWomancardiovascular risk factormenoxidized low density lipoproteintrait
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
This is a continuation of a previous study (San Antonio Family Osteoporosis Study, or SAFOS) which enrolled 897 individuals from 34 families from 1997-2001, in conjunction with the San Antonio Family Heart Study (SAFHS). From the results of the SAFOS study, strong evidence was detected for linkage of forearm bone mineral density (BMD) to a region on chromosome 4p (multipoint lod score = 4.8). Associations were also observed between increased BMD with both diabetes and serum insulin levels, although this latter correlation as not independent of obesity. Also observed was a strong positive correlation between carotid wall thickening, a subclinical measure of atherosclerosis, and BMD in women ages 40 years and older, although in men a significant correlation was also detected but in the opposite direction.
This study seeks to enroll 950 subjects already enrolled in the SAFHS who will be returning for their 10-year visit. Most will have also been enrolled in the first SAFOS study, which included measurement of bone mineral density. BMD will be re-measured to enable investigators to determine whether there has been a change in BMD over five years. It is hypothesized that serum insulin levels will be positively correlated with five-year change in BMD, and that oxidized LDL concentrations will be a common risk factor predisposing subjects to both osteoporosis and subclinical atherosclerosis. A genome scan of five-year changes will be performed, and it is anticipated that multiple linkages to this trait will be identified, some of which will overlap with loci previously shown to be linked to the baseline measure of BMD, and others not previously identified as being linked to BMD. Molecular studies will be initiated, with the goal of fine-mapping the QTL on chromosome 4 identified as being linked to BMD. To begin this effort, investigators will identify and genotype SNPs within positional candidate genes that map to the linked region and will perform association analyses to detect whether linkage disequilibrium over the previous five years are associated with hyperinsulinemia or cardiovascular risk factors. They will also perform genetic studies, including determining whether any quantitative trait loci influence the rate of change of bone mineral density.
这个子项目是众多研究子项目之一
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAN M BRUDER其他文献
JAN M BRUDER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAN M BRUDER', 18)}}的其他基金
GENETICS OF BONE DENSITY IN MEXICAN AMERICANS - CONTINUATION
墨西哥裔美国人的骨密度遗传学 - 续
- 批准号:
7378153 - 财政年份:2006
- 资助金额:
$ 3.24万 - 项目类别:
PREVENTION OF BONE LOSS WITH ALENDRONATE IN PROSTATE CANCER WITH HORMONE DEPRIVA
阿仑膦酸钠在激素剥夺治疗中预防前列腺癌中的骨丢失
- 批准号:
7378152 - 财政年份:2006
- 资助金额:
$ 3.24万 - 项目类别:
GENETICS OF BONE DENSITY IN MEXICAN AMERICANS - CONTINUATION
墨西哥裔美国人的骨密度遗传学 - 续
- 批准号:
7204762 - 财政年份:2005
- 资助金额:
$ 3.24万 - 项目类别:
PREVENTION OF BONE LOSS WITH ALENDRONATE IN PROSTATE CANCER WITH HORMONE DEPRIVA
阿仑膦酸钠在激素剥夺治疗中预防前列腺癌中的骨丢失
- 批准号:
7204761 - 财政年份:2005
- 资助金额:
$ 3.24万 - 项目类别:
Alendronate Therapy for Bone Loss in Prostate Cancer
阿仑膦酸钠治疗前列腺癌骨质流失
- 批准号:
6972353 - 财政年份:2004
- 资助金额:
$ 3.24万 - 项目类别:
Acculturation/Diet/Workload Effect on Bone Density in MA
文化适应/饮食/工作量对 MA 骨密度的影响
- 批准号:
6972354 - 财政年份:2004
- 资助金额:
$ 3.24万 - 项目类别:
EFFECT OF ANTIRESORPTIVES IN PATIENTS W/ PAGETS DISEASE
抗吸收剂对佩吉特病患者的影响
- 批准号:
6653430 - 财政年份:2002
- 资助金额:
$ 3.24万 - 项目类别:
DETERMINATION OF RATE OF BONE LOSS IN MEN UNDERGOING CASTRATION FOR CANCER
因癌症而接受去势的男性骨质流失率的测定
- 批准号:
6653464 - 财政年份:2002
- 资助金额:
$ 3.24万 - 项目类别:
相似海外基金
Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
- 批准号:
24K21101 - 财政年份:2024
- 资助金额:
$ 3.24万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Body composition and atherosclerosis-related biomarkers in women with endometriosis
子宫内膜异位症女性的身体成分和动脉粥样硬化相关生物标志物
- 批准号:
23K15842 - 财政年份:2023
- 资助金额:
$ 3.24万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Targeted multimodal stimuli-responsive nanogels for atherosclerosis imaging and therapy
用于动脉粥样硬化成像和治疗的靶向多模式刺激响应纳米凝胶
- 批准号:
2880683 - 财政年份:2023
- 资助金额:
$ 3.24万 - 项目类别:
Studentship
The Epigenetic Regulator Prdm16 Controls Smooth Muscle Phenotypic Modulation and Atherosclerosis Risk
表观遗传调节因子 Prdm16 控制平滑肌表型调节和动脉粥样硬化风险
- 批准号:
10537602 - 财政年份:2023
- 资助金额:
$ 3.24万 - 项目类别:
Role of IL-6 trans signaling in atherosclerosis development and late-stage pathogenesis
IL-6反式信号传导在动脉粥样硬化发展和晚期发病机制中的作用
- 批准号:
10652788 - 财政年份:2023
- 资助金额:
$ 3.24万 - 项目类别:
Novel Mechanisms Underlying the Development of Atherosclerosis
动脉粥样硬化发展的新机制
- 批准号:
10589484 - 财政年份:2023
- 资助金额:
$ 3.24万 - 项目类别:
Alcohol Regulation of Endothelial Plasticity in Atherosclerosis
酒精对动脉粥样硬化内皮可塑性的调节
- 批准号:
10585070 - 财政年份:2023
- 资助金额:
$ 3.24万 - 项目类别:
From genotype to phenotype in a GWAS locus: the role of REST in atherosclerosis
GWAS 位点从基因型到表型:REST 在动脉粥样硬化中的作用
- 批准号:
10570469 - 财政年份:2023
- 资助金额:
$ 3.24万 - 项目类别:
The role of extracellular vesicle-associated MicroRNAs in HIV-associated atherosclerosis
细胞外囊泡相关 MicroRNA 在 HIV 相关动脉粥样硬化中的作用
- 批准号:
10619831 - 财政年份:2023
- 资助金额:
$ 3.24万 - 项目类别:














{{item.name}}会员




